Published online before print January 16, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ß and induce IFN-
ß-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs
,
,2
* Departments of Pathology and
Pharmacology and
Center for AIDS Research, Case Western Reserve University, Cleveland, Ohio, USA
2 Correspondence: Department of Pathology, WRB 5534, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106-7288, USA. E-mail: cvh3{at}cwru.edu
Deoxycytidyl-deoxyguanosine [(CpG)3] oligodeoxynucleotides (ODNs) signal through TLR9 to induce type-I IFN (IFN-
ß) and IFN-
ß-dependent MHC-I cross-presentation of exogenous antigens by dendritic cells (DCs). A puzzle was presented by our observation that three ODN classes, CpG-A, CpG-B, and CpG-C, had similar efficacy for induction of IFN-
ß-dependent MHC-I antigen cross-presentation by myeloid DCs despite greatly differing for induction of IFN-
ß (CpG-A>CpG-C>>CpG-B). All ODN classes similarly enhanced plasmacytoid DC (pDC) presentation of exogenous MHC-I-restricted peptide, although pDCs did not cross-process protein antigen. MHC-I and the transporter for antigen presentation were induced by all ODN classes or IFN-
. CpG-B ODNs were slightly more potent than CpG-A or CpG-C ODNs for induction of low levels of IFN-
ß but less efficacious at high concentrations than CpG-A or CpG-C ODNs. Low levels of IFN-
ß induced by CpG-B ODNs sufficed for full induction of MHC-I cross-presentation. Thus, CpG-B ODNs are slightly more potent but less efficacious than CpG-A and CpG-C ODNs for induction of IFN-
ß. High sensitivity to IFN-
ß allows CpG-B ODNs to be equally efficacious for induction of MHC-I cross-presentation. CpG-B ODNs may be effective for inducing therapeutic responses that require low levels of IFN-
ß and may avoid unnecessarily high induction of IFN-
ß.
Key Words: CpG oligodeoxynucleotides antigen presentation Toll-like receptor 9 dendritic cells type I interferon
This article has been cited by other articles:
![]() |
Y. C. Liu, R. C. Gray, G. A. D. Hardy, J. Kuchtey, D. W. Abbott, S. N. Emancipator, and C. V. Harding CpG-B Oligodeoxynucleotides Inhibit TLR-Dependent and -Independent Induction of Type I IFN in Dendritic Cells J. Immunol., April 1, 2010; 184(7): 3367 - 3376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Flores, D. D. Desai, M. Downie, B. Liang, M. P. Reilly, S. E. McKenzie, and R. Clynes Dominant Expression of the Inhibitory Fc{gamma}RIIB Prevents Antigen Presentation by Murine Plasmacytoid Dendritic Cells J. Immunol., December 1, 2009; 183(11): 7129 - 7139. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mouries, G. Moron, G. Schlecht, N. Escriou, G. Dadaglio, and C. Leclerc Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation Blood, November 1, 2008; 112(9): 3713 - 3722. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Meyer-Wentrup, D. Benitez-Ribas, P. J. Tacken, C. J. A. Punt, C. G. Figdor, I. J. M. de Vries, and G. J. Adema Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-{alpha} production Blood, April 15, 2008; 111(8): 4245 - 4253. [Abstract] [Full Text] [PDF] |
||||